In chronic lymphocytic leukemia, the ratio of PER2 to CRY1 is suggested to be a prognostic marker that predicts survival outcomes of patients, with a low PER2:CRY1 having the best outcomes [88]. The gene discussed is CRY1; the disease is B-cell chronic lymphocytic leukemia.